Phytochemicals as future drugs for Parkinson's disease: A comprehensive review

Reviews in the Neurosciences

Volumn 27, Issue 6, 2016, Pages 651-668

  Shahpiri, Zahra ^a   Bahramsoltani, Roodabeh ^a,b   Hosein Farzaei, Mohammad ^c,d   Farzaei, Fatemeh ^d   Rahimi, Roja ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Medicinal plant; Natural product; Neurodegenerative disease; Parkinson's disease; Phytochemical

Indexed keywords

ALKALOID DERIVATIVE; ALPHA SYNUCLEIN; AMINO ACID DERIVATIVE; CARBOHYDRATE DERIVATIVE; CASPASE 3; CASPASE 8; CASPASE 9; CINNAMIC ACID DERIVATIVE; CURCUMIN; DOPAMINE; FATTY ACID DERIVATIVE; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIGNAN DERIVATIVE; NATURAL PRODUCT; NEUROTROPHIC FACTOR; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; PROSTAGLANDIN E2; PROTEIN BAX; PROTEIN BCL 2; STILBENE DERIVATIVE; TERPENE DERIVATIVE; ANTIPARKINSON AGENT; NERVE GROWTH FACTOR;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL LOSS; DOPAMINERGIC NERVE CELL; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIPARKINSON AGENTS; APOPTOSIS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; NERVE GROWTH FACTORS; PARKINSON DISEASE;

EID: 84983339479     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2016-0004     Document Type: Article

References (93)

1. Agim, Z.S., and Cannon, J.R. (2015). Dietary factors in the etiology of Parkinson's disease. BioMed. Res. Int. 2015, Article ID 672838, 16 pages.
2. Anandhan, A., Tamilselvam, K., Radhiga, T., Rao, S., Essa, M.M., and Manivasagam T. (2012). Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/ probenecid induced Parkinson's disease. Brain Res. 1433, 104-113.
3. Anderson, W., Barrows, M., Lopez, F., Rogers, S., Ortiz-Coffie, A., Norman, D., Hodges, J., McDonald, K., Barnes, D., McCall, S., et al. (2012). Investigation of the anxiolytic effects of naringenin, a component of Mentha aquatica, in the male Sprague-Dawley rat. Holist. Nurs. Pract. 26, 52-57.
4. Ang-Lee, M.K., Moss, J., and Yuan, C.S. (2001). Herbal medicines and perioperative care. J. Am. Med. Assoc. 286, 208-216.
5. Ardah, M.T., Paleologou, K.E., Lv, G., Menon, S.A., Abul Khair, S.B., Lu, J.H., Safieh-Garabedian, B., Al-Hayani, A.A., Eliezer, D., Li, M., et al. (2015). Ginsenoside Rb1 inhibits fibrillation and toxicity of α-synuclein and disaggregates preformed fibrils. Neurobiol. Dis. 74, 89-101.
6. Bahramsoltani, R., Farzaei, M.H., Farahani, M.S., and Rahimi, R. (2015). Phytochemical constituents as future antidepressants: A comprehensive review. Rev. Neurosci. 26, 699-719.
7. Barbosa-Filho, J.M., Piuvezam, M.R., Moura, M.D., Silva, M.S., Lima, K.V.B., da-Cunha, E.V.L., Fechine, I.M., and Takemura, O.S. (2006). Anti-inflammatory activity of alkaloids: A twenty-century review. Braz. J. Pharmacogn. 16, 109-139.
8. Basheer, L., and Kerem, Z. (2015). Interactions between CYP3A4 and dietary polyphenols. Oxid. Med. Cell. Longev. 2015, Article ID 854015, 15 pages.
9. Bassani, T.B., Vital, M.A., and Rauh, L.K. (2015). Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs. Arq. Neuropsiquiatr. 73, 616-623.
10. Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., and Jackson-Lewis, V.R. (2015). Oxidative stress and Parkinson's disease. Front. Neuroanat. 9, 91.
11. Brandenburg, L.O., Kipp, M., Lucius, R., Pufe, T., and Wruck, C.J. (2010). Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm. Res. 59, 443-450.
12. Chakroborty, D., Sarkar, C., Yu, H., Wang, J., Liu, Z., Dasgupta, P.S., and Basu, S. (2011). Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Krupel-like factor-2 expression in tumor endothelial cells. Proc. Natl. Acad. Sci. USA. 108, 20730-20735.
13. Chao, J., Yu, M.S., Ho, Y.S., Wang, M., and Chang, R.C. (2008). Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic. Biol. Med. 45, 1019-1026.
14. Chen, J.H., Ou, H.P., Lin, C.Y., Lin, F.J., Wu, C.R., Chang, S.W., and Tsai, C.W. (2012). Carnosic acid prevents 6-hydroxydopamineinduced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem. Res. Toxicol. 25, 1893-1901.
15. Cheung, Z.H., and Ip, N.Y. (2009). The emerging role of autophagy in Parkinson's disease. Mol. Brain 2, 29.
16. Choi, S.Y., Son, T.G., Park, H.R., Jang, Y.J., Oh, S.B., Jin, B., and Lee, J. (2012). Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model. J. Neurosci. Res. 90, 1842-1849.
17. Cleren, C., Calingasan, N.Y., Chen, J., and Beal, M.F. (2005). Celastrol protects against MPTP-and 3-nitropropionic acid-induced neurotoxicity. J. Neurochem. 94, 995-1004.
18. De Sousa Falc?, H., Leite, J.A., Barbosa-Filho, J.M., de Athayde-Filho, P.F., de Oliveira Chaves, M.C., Moura, M.D., Ferreira, A.L., de Almeida, A.B.A., Souza-Brito, A.R.M., de F?ima Formiga Melo Diniz, M., et al. (2008). Gastric and duodenal antiulcer activity of alkaloids: A review. Molecules 13, 3198-3223.
19. Deng, C., Tao, R., Yu, S.Z., and Jin, H. (2012a). Sulforaphane protects against 6-hydroxydopamine-induced cytotoxicity by increasing expression of heme oxygenase-1 in a PI3K/Akt-dependent manner. Mol. Med. Rep. 5, 847-851.
20. Deng, C., Tao, R., Yu, S.Z., and Jin, H. (2012b). Inhibition of 6-hydroxydopamine-induced endoplasmic reticulum stress by sulforaphane through the activation of Nrf2 nuclear translocation. Mol. Med. Rep. 6, 215-219.
21. Du, T., Li, L., Song, N., Xie, J., and Jiang, H. (2010). Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells. Int. J. Toxicol. 29, 625-633.
22. Du, X.X., Xu, H.M., Jiang, H., Song, N., Wang, J., and Xie, J.X. (2012). Curcumin protects nigral dopaminergic neurons by ironchelation in the 6-hydroxydopamine rat model of Parkinson's disease. Neurosci. Bull. 28, 253-258.
23. Fabio, G.D., Romanucci, V., Marco, A.D., and Zarrelli, A. (2014). Triterpenoids from Gymnema sylvestre and their pharmacological activities. Molecules 19, 10956-10981.
24. Farahani, M.S., Bahramsoltani, R., Farzaei, M.H., Abdollahi, M., and Rahimi, R. (2015). Plant-derived natural medicines for the management of depression: An overview of mechanisms of action. Rev. Neurosci. 26, 305-321.
25. Farzaei, M.H., Abdollahi, M., and Rahimi, R. (2015). Role of dietary polyphenols in the management of peptic ulcer. World J. Gastroenterol. 21, 6499-6517.
26. Farzaei, M.H., Bahramsoltani, R., Rahimi, R., Abbasabadi, F., and Abdollahi, M. (2016). A systematic review of plant-derived natural compounds for anxiety disorders. Curr. Top. Med. Chem. Epub ahead of print.
27. Filomeni, G., Graziani, I., De Zio, D., Dini, L., Centonze, D., Rotilio, G., and Ciriolo, M.R. (2012). Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: Possible implications for Parkinson's disease. Neurobiol. Aging 33, 767-785.
28. Fu, R.H., Harn, H.J., Liu, S.P., Chen, C.S., Chang, W.L., Chen, Y.M., Huang, J.E., Li, R.J., Tsai, S.Y., Hung, H.S., et al. (2014). n-Butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease. PLoS ONE 9:e85305.
29. Fujikawa, T., Kanada, N., Shimada, A., Ogata, M., Suzuki, I., Hayashi, I., and Nakashima, K. (2005). Effect of sesamin in Acanthopanax senticosus HARMS on behavioral dysfunction in rotenone-induced parkinsonian rats. Biol. Pharm. Bull. 28, 169-172.
30. Garc?, C., Palomo-Garo, C., Garc?-Arencibia, M., Ramos, J., Pertwee, R., and Fern?dez-Ruiz, J. (2011). Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease. Br. J. Pharmacol. 163, 1495-1506.
31. Geng, X., Tian, X., Tu, P., and Pu, X. (2007). Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease. Eur. J. Pharmacol. 564, 66-74.
32. Gonzez-Burgos, E., and Gez-Serranillos, M.P. (2012). Terpene compounds in nature: A review of their potential antioxidant activity. Curr. Med. Chem. 19, 5319-5341.
33. Gopalakrishna, A., and Alexander, S.A. (2015). Understanding Parkinson disease: A complex and multifaceted illness. J. Neurosci. Nurs. 47, 320-326.
34. Ham, A., Lee, H.J., Hong, S.S., Lee, D., and Mar, W. (2012). Moracenin D from Mori cortex radicis protects SH-SY5Y cells against dopamine-induced cell death by regulating nurr1 and α-synuclein expression. Phytother. Res. 26, 620-624.
35. Han, J.M., Lee, Y.J., Lee, S.Y., Kim, E.M., Moon, Y., Kim, H.W., and Hwang, O. (2007). Protective effect of sulforaphane against dopaminergic cell death. J. Pharmacol. Exp. Ther. 321, 249-256.
36. Huang, J.Z., Chen, Y.Z., Su, M., Zheng, H.F., Yang, Y.P., Chen, J., and Liu, C.F. (2010). dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease. Neurosci. Lett. 475, 89-94.
37. Ikram, N.K., Zhan, X., Pan, X.W., King, B.C., and Simonsen, H.T. (2015). Stable heterologous expression of biologically active terpenoids in green plant cells. Front. Plant Sci. 18, 129.
38. Kabuto, H., Nishizawa, M., Tada, M., Higashio, C., Shishibori, T., and Kohno, M. (2005). Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem. Res. 30, 325-332.
39. Khadira Sereen, A., Priya, N., and Vijayalakshmi, K. (2014). Effect of sesamol and folic acid on behavioural activity and antioxidant profile of rats induced with 6-hydroxy dopamine. Int. J. Pharmacogn. Phytochem. Res. 6, 930-935.
40. Kim, H.G., Ju, M.S., Ha, S.K., Lee, H., Lee, H., Kim, S.Y., and Oh M.S. (2012a). Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol. Pharm. Bull. 35, 1287-1294.
41. Kim, K.H., Song, K., Yoon, S.H., Shehzad, O., Kim, Y.S., and Son, J.H. (2012b). Rescue of PINK1 protein null-specific mitochondrial complex IV deficits by ginsenoside reactivation of nitric oxide signaling. J. Biol. Chem. 287, 44109-44120.
42. Klepacka, J., Gujska, E., and Michalak, J. (2011). Phenolic compounds as cultivar-and variety-distinguishing factors in some plant products. Plant Foods Hum. Nutr. 66, 64-69.
43. Kumar, H., Kim, I.S., More, S.V., Kim, B.W., Bahk, Y.Y., and Choi, D.K. (2013). Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model. Evid. Based Complement Alternat. Med. 2013, Article ID 514095, 13 pages.
44. Lakhan, S.E., and Vieira, K.F. (2010). Nutritional and herbal supplements for anxiety and anxiety-related disorders: Systematic review. Nutr. J. 9, 42.
45. Lastres-Becker, I., Molina-Holgado, F., Ramos, J.A., Mechoulam, R., and Fern?dez-Ruiz, J. (2005). Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease. Neurobiol. Dis. 19, 96-107.
46. Leal, L.K.A.M., J?ior, H.N., Cunha, G.M.A., Moraes, M.O., Pessoa, C., Oliveira, R.A., Silveira, E.R., Canuto, K.M., and Viana, G.S.B. (2005). Amburoside A, a glucoside from Amburana cearensis, protects mesencephalic cells against 6-hydroxydopamineinduced neurotoxicity. Neurosci. Lett. 388, 86-90.
47. Lee, Y., Park, H.R., Chun, H.J., and Lee, J. (2015). Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization. J. Neurosci. Res. 93, 755-765.
48. Levites, Y., Weinreb, O., Maor, G., Youdim, M.B., and Mandel, S. (2001). Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinduced dopaminergic neurodegeneration. J. Neurochem. 78, 1073-1082.
49. Li, S., and Pu, X.P. (2011). Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinduced mouse model of Parkinson's disease. Biol. Pharm. Bull. 34, 1291-1296.
50. Li, Y.Y., Lu, J.H., Li, Q., Zhao, Y.Y., and Pu, X.P. (2008). Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP+) in primary cultures of rat mesencephalic neurons. Eur. J. Pharmacol. 579, 134-140.
51. Li, B., Jeong, G.S., Kang, D.G., Lee, H.S., and Kim, Y.C. (2009). Cytoprotective effects of lindenenyl acetate isolated from Lindera strychnifolia on mouse hippocampal HT22 cells. Eur. J. Pharmacol. 614, 58-65.
52. Li, B.Y., Yuan, Y.H., Hu, J.F., Zhao, Q., Zhang, D.M., and Chen, N.H. (2011). Protective effect of Bu-7, a flavonoid extracted from Clausena lansium, against rotenone injury in PC12 cells. Acta Pharmacol. Sin. 32, 1321-1326.
53. Liang, Z., Shi, F., Wang, Y., Lu, L., Zhang, Z., Wang, X., and Wang, X. (2011). Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury. Neurosci. Lett. 497, 104-109.
54. Liu, H.Q., Zhang, W.Y., Luo, X.T., Ye, Y., and Zhu, X.Z. (2006). Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor. Br. J. Pharmacol. 148, 314-325.
55. Mandel, S., Maor, G., and Youdim, M.B. (2004). Iron and a-synuclein in the substantia nigra of MPTP-treated mice: Effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate. J. Mol. Neurosci. 24, 401-416.
56. Meng, H., Li, C., Feng, L., Cheng, B., Wu, F., Wang, X., Li, Z., and Liu, S. (2007). Effects of Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in cultured PC12. Int. J. Dev. Neurosci. 25, 509-514.
57. Miller, R.L., James-Kracke, M., Sun, G.Y., and Sun, A.Y. (2009). Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 34, 55-65.
58. Moon, H.E., and Paek, S.H. (2015). Mitochondrial dysfunction in Parkinson's disease. Exp. Neurobiol. 24, 103-116.
59. Morroni, F., Tarozzi, A., Sita, G., Bolondi, C., Moraga, J.M.Z., Cantelli-Forti, G., and Hrelia, P. (2013). Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. Neurotoxicology 36, 63-71.
60. Mu, X., He, G., Cheng, Y., Li, X., Xu, B., and Du, G. (2009). Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacol. Biochem. Behav. 92, 642-648.
61. Nirumand, M.C., Farzaei, M.H., and Amin, G. (2015). Medicinal properties of Peganum harmala L. in traditional Iranian medicine and modern phytotherapy: A review. J. Tradit. Chin. Med. 35, 104-109.
62. Ortiz-Ortiz, M.A., Mor?, J.M., Ruiz-Mesa, L.M., Niso-Santano, M., Bravo-SanPedro, J.M., Gez-S?chez, R., Gonzez-Polo, R.A., and Fuentes, J.M. (2010). Curcumin exposure induces expres sion of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells. Neurosci. Lett. 468, 120-124.
63. Paduch, R., Kandefer-Szerszen, M., Trytek, M., and Fiedurek, J. (2007). Terpenes: Substances useful in human healthcare. Arch. Immunol. Ther. Exp. 55, 315-327.
64. Pandey, K.B., and Rizvi, S.I. (2009). Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2, 270-278.
65. Park, B.C., Lee, Y.S., Park, H.J., Kwak, M.K., Yoo, B.K., Kim, J.Y., and Kim, J.A. (2007). Protective effects of fustin, a flavonoid from Rhus verniciflua Stokes, on 6-hydroxydopamine-induced neuronal cell death. Exp. Mol. Med. 39, 316-326.
66. Park, J.A., Kim, S., Lee, S.Y., Kim, C.S., Kim do, K, Kim, S.J., and Chun, H.S. (2008). Beneficial effects of carnosic acid on dieldrin-induced dopaminergic neuronal cell death. NeuroReport 19, 1301-1304.
67. Park, G., Kim, H.G., Ju, M.S., Ha, S.K., Park, Y., Kim, S.Y., and Oh, M.S. (2013). 6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via antineuroinflammation. Acta Pharmacol. Sin. 34, 1131-1139.
68. Pasban-Aliabadi, H., Esmaeili-Mahani, S., Sheibani, V., Abbasnejad, M., Mehdizadeh, A., and Yaghoobi, M.M. (2013). Inhibition of 6-hydroxydopamine-induced PC12 cell apoptosis by olive (Olea europaea L.) leaf extract is performed by its main component oleuropein. Rejuv. Res. 16, 134-142.
69. Pez, H.J., Carrillo, S.C., Garc?, E., Ruiz-Mar, G., Pez-Tamayo, R., and Chavarr?, A. (2014). Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Toxicology 319, 38-43.
70. Priyadarshi, A., Khuder, S.A., Schaub, E.A., and Priyadarshi, S.S. (2001). Environmental risk factors and Parkinson's disease: A metaanalysis. Environ. Res. 86, 122-127.
71. Qualls, Z., Brown, D., Ramlochansingh, C., Hurley, L.L., and Tizabi, Y. (2014). Protective effects of curcumin against rotenone and salsolinol-induced toxicity: Implications for Parkinson's disease. Neurotoxicol. Res. 25, 81-89.
72. Reinisalo, M., K?lund, A., Koskela, A., Kaarniranta, K., and Karjalainen, R.O. (2015). Polyphenol stilbenes: Molecular mechanisms of defence against oxidative stress and aging-related diseases. Oxid. Med. Cell. Longev. 2015, Article ID 340520, 24 pages.
73. Rekha, K.R., Selvakumar, G.P., and Sivakamasundari, R.I. (2014). Effects of syringic acid on chronic MPTP/probenecid induced motor dysfunction, dopaminergic markers expression and neuroinflammation in C57BL/6 mice. Biomed. Aging Pathol. 4, 95-104.
74. Ren, P., Jiang, H., Li, R., Wang, J., Song, N., Xu, H.M., and Xie, J.X. (2009). Rosmarinic acid inhibits 6-OHDA-induced neurotoxicity by anti-oxidation in MES23.5 cells. J. Mol. Neurosci. 39, 220-225.
75. Ryu, H.W., Oh, W.K., Jang, I.S., and Park, J. (2013). Amurensin G induces autophagy and attenuates cellular toxicities in a rotenone model of Parkinson's disease. Biochem. Biophys. Res. Commun. 433, 121-126.
76. Shay, J., Elbaz, H.A., Lee, I., Zielske, S.P., Malek M.H., and Hutemann, M. (2015). Molecular mechanisms and therapeutic effects of (-)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid. Med. Cell. Longev. 2015, Article ID 181260, 13 pages.
77. Shukla, V., Phulara, S.C., Yadav, D., Tiwari, S., Kaur, S., Gupta, M.M., Nazir, A., and Pandey, R. (2012). Iridoid compound 10-O-transp-coumaroylcatalpol extends longevity and reduces á synuclein aggregation in Caenorhabditis elegans. CNS Neurol. Disord. Drug Targets 11, 984-992.
78. Singh, A., Naidu, P.S., and Kulkarni, S.K. (2003). Quercetin potentiates L-dopa reversal of drug-induced catalepsy in rats: Possible COMT/MAO inhibition. Pharmacology 68, 81-88.
79. Sodagari, H.R., Farzaei, M.H., Bahramsoltani, R., Abdolghaffari, A.H., Mahmoudi, M., and Rezaei, N. (2015). Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease. Exp. Rev. Gastroenterol. Hepatol. 9, 807-820.
80. Stalikas, C.D. (2007). Extraction, separation, and detection methods for phenolic acids and flavonoids. J. Sep. Sci. 30, 3268-3295.
81. Sun, X., Cao, Y.B., Hu, L.F., Yang, Y.P., Li, J., Wang, F., and Liu, C.F. (2011). ASICs mediate the modulatory effect by paeoniflorin on α-synuclein autophagic degradation. Brain Res. 1396, 77-87.
82. Tai, K.K., and Truong, D.D. (2010). (-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyltrichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells. Neurosci. Lett. 482, 183-187.
83. Tamilselvam, K., Braidy, N., Manivasagam, T., Essa, M.M., Prasad, N.R., Karthikeyan, S., Thenmozhi, A.J., Selvaraju, S., and Guillemin, G.J. (2013). Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxid. Med. Cell. Longev. 2013, Article ID 102741, 11 pages.
84. Vauzour, D., Buonfiglio, M., Corona, G., Chirafisi, J., Vafeiadou, K., Angeloni, C., Hrelia, S., Hrelia, P., and Spencer, J.P. (2010). Sulforaphane protects cortical neurons against 5-S-cysteinyldopamine-induced toxicity through the activation of ERK1/2, Nrf-2 and the upregulation of detoxification enzymes. Mol. Nutr. Food Res. 54, 532-542.
85. Wang, X.J., and Xu, J.X. (2005). Salvianic acid A protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Neurosci. Res. 51, 129-138.
86. Wang, Y., Xu, H., Fu, Q., Ma, R., and Xiang, J. (2011). Protective effect of resveratrol derived from Polygonum cuspidatum and its liposomal form on nigral cells in parkinsonian rats. J. Neurol. Sci. 304, 29-34.
87. Wang, S., Jing, H., Yang H, Liu, Z., Guo, H., Chai, L., and Hu, L. (2015). Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease. J. Ethnopharmacol. 164, 247-255.
88. Wu, C.R., Tsai, C.W., Chang, S.W., Lin, C.Y., Huang, L.C., and Tsai, C.W. (2015). Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: Involvement of antioxidative enzymes induction. Chem. Biol. Interact. 225, 40-46.
89. Xie, C.L., Gu, Y., Wang, W.W., Lu, L., Fu, D.L., Liu, A.J., Li, H.Q., Li, J.H., Lin, Y., and Tang, W.J. (2013). Efficacy and safety of Suanzaoren decoction for primary insomnia: A systematic review of randomized controlled trials. BMC Complement. Alternat. Med. 13, 18.
90. Xu, C.L., Qu, R., Zhang, J., Li, L.F., and Ma, S.P. (2013). Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats. Fitoterapia 90, 112-118.
91. Ye, Q., Ye, L., Xu, X., Huang, B., Zhang, X., Zhu, Y., and Chen, X. (2012). Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway. BMC Complement. Alternat. Med. 12, 82.
92. Yu, C.H., Ishii, R., Yu, S.C., and Takeda, M. (2014). Yokukansan and its ingredients as possible treatment options for schizophrenia. Neuropsychiatr. Dis Treat. 10, 1629-1634.
93. Zhao, G., Zheng, X.W., Qin, G.W., Gai, Y., Jiang, Z.H., and Guo, L.H. (2009). In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of D3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.). Cell. Mol. Life Sci. 66, 1617-1629.